Business
Australian Clinical Labs terms: $408.6m IPO at $4 a share – The Australian Financial Review
Stockbrokers Bank of America and Goldman Sachs have widened the buyer search for IPO hopeful Australian Clinical Labs.
Stockbrokers Bank of America and Goldman Sachs have widened the buyer search for IPO hopeful Australian Clinical Labs.
The brokers equities desks sent terms to fund managers on Wednesday morning, and said they would be back with an institutional bookbuild to sell shares and lock in the listing on Tuesday April 27.
Street Talk. Erin Jonasson
The term sheet said Australian Clinical Labs would seek to raise $408.6 million at $4 a share.
The price represented 15-times forecast profit for the 2021 calendar…
-
General10 hours agoNew Zealand wants more ‘automated decision-making’ in its welfare system. Could that lead to Robodebt 2.0?
-
General12 hours agoFrom Humpty Doo to the bush, these voters’ views reflect the challenge for federal politicians
-
Noosa News11 hours agoMajor emergency rescue following boat capsizing off Main Beach on the Gold Coast
-
General12 hours agoPolice say man shot dead in Footscray had charged at officers armed with knife